Information about Apotheek Defever
My details
*
*
*

Apotheek Defever (SRL)

Company information

Status
Active

Enterprise number

BE0878.760.612

VAT liability
Yes
Established
12-01-2006
Last balance sheet year
2024
Company size
Small 1,9 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Apotheek Defever

2024 2023 2022 2021
Profit/Loss 123,917 -11 % 138,624 11 % 125,206 6 % 118,646
Equity 1,243,307 11 % 1,119,390 10 % 1,014,218 10 % 918,984
Gross margin 400,006 2 % 392,529 4 % 378,090 19 % 317,075
Employees 1.9 1.9 2.2 2.2

Publications from Apotheek Defever

Date Publication
10-03-2025 Modification Legal Form - Resignations - Appointments (NL)
12-02-2018 Registered Office (NL)
19-02-2014 Capital - Shares (NL)
31-01-2006 Constitution (NL)

Frequently asked questions

What is the VAT number of Apotheek Defever?
The VAT number of Apotheek Defever is BE 0878.760.612.
Wat is the PEPPOL ID of Apotheek Defever?
The PEPPOL ID of Apotheek Defever is 0208:0878760612. Log in or start a free trial to see the full overview.
When was Apotheek Defever founded?
Apotheek Defever was founded on 12-01-2006.
What is the address of Apotheek Defever?
The current registered office of Apotheek Defever is located at Opperstraat 128, 1770 Liedekerke.
When was the last time Apotheek Defever filed their annual financial statements?
The most recent financial statements of Apotheek Defever were filed on 30-07-2025.
How many employees does Apotheek Defever have?
There are 1,9 FTEs working at Apotheek Defever according to the staff figures in the most recent financial statements.
What is the annual turnover of Apotheek Defever?
At the time of its most recent financial statements, Apotheek Defever did not publish any turnover figures. Apotheek Defever reported a gross margin of €400,005.59.